Jacqueline E. Shea - 10 May 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Executive Officer
Signature
/s/ Jacqueline E. Shea
Issuer symbol
INO
Transactions as of
10 May 2022
Net transactions value
$0
Form type
4
Filing time
11 May 2022, 17:03:48 UTC
Previous filing
28 Mar 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Option Award $0 +309,400 $0.000000 309,400 10 May 2022 Common Stock 309,400 $2.49 Direct F1
transaction INO Restricted Stock Unit Award $0 +198,000 $0.000000 198,000 10 May 2022 Common Stock 198,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The vesting schedule for the 309,400 options is as follows: 77,350 shares vested on May 10, 2022; 77,350 shares will vest on May 10, 2023; 77,350 shares will vest on May 10, 2024; 77,350 shares will vest on May 10, 2025.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares will vest on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.